Modulation of cytochrome P-450 dependent monooxygenases in streptozotocin-induced diabetic hamster: I. Effects of propofol on defluorination and cytochrome P-450 activities

Acta Anaesthesiologica Sinica

Volumn 38, Issue 1, 2000, Pages 15-21

  Chen, Ta Liang ^a   Chang, Huai Chia ^a   Chen, Tyng Guey ^a   Tai, Yu Tint ^a   Chen, Ruei Ming ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytochrome P 450; Diabetes mellitus, experimental; Microsomes, liver, kidney; Propofol; Streptozotocin

Indexed keywords

ANILINE; BENZO[A]PYRENE; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; ENFLURANE; ERYTHROMYCIN; N DEMETHYLASE; PENTOXYRESORUFIN; PENTOXYRESORUFIN DEALKYLASE; PROPOFOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STREPTOZOCIN; UNSPECIFIC MONOOXYGENASE;

ANESTHESIA; ARTICLE; CONTROLLED STUDY; DEFLUORINATION; DIABETES MELLITUS; DRUG EFFECT; DRUG METABOLISM; ENZYME REGULATION; HAMSTER; IN VITRO STUDY; KIDNEY MICROSOME; LIVER MICROSOME; MALE; METABOLIC INHIBITION; NONHUMAN;

ANIMALS; CRICETINAE; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS, EXPERIMENTAL; DRUG INTERACTIONS; ENFLURANE; FLUORINE; MALE; MESOCRICETUS; PROPOFOL; STREPTOZOCIN;

EID: 0034039116     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Guengerich FP: Reaction and significance of cytochrome P-450 enzymes. J Biol Chem 266:10019-10022, 1991.
2. Chen TL, Chen SH, Tai TY, Chao CC, Park SS, Guengerich FP, Ueng TH: Induction and suppression of renal and hepatic cytochrome P-450-dependent monooxygenases by acute and chronic streptozotocin diabetes in hamster. Arch Toxicol 70: 202-208, 1996.
3. Ueng TH, Ueng YF, Tsai JN, Chao IC, Chen TL, Park SS, Guengerich FP: Induction and inhibition of cytochrome P-450-dependent monooxygenase in hamster tissues by ethanol. Toxicology 81:141-154, 1993.
4. Ueng TH, Ueng YF, Chen TL, Park SS, Iwasaki M, Guengerich FP: Induction of cytochrome P-450-dependent monooxygenase in hamster tissues by fasting. Toxicol Appl Pharm 19: 66-73, 1993.
5. Cousins MJ, Mazze RI: Methoxyflurane nephrotoxicity: A study of dose response in man. JAMA 225:1611-1616, 1973.
6. Holaday DA, Smith FR: Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 54:100-106, 1981.
7. Frink EJ Jr. Ghantous H, Malan TP, Morgan S, Fernando J, Gandolfi AJ, Brown BR Jr.: Plasma inorganic fluoride with sevoflurane anesthesia: Correlation with indices of hepatic and renal function. Anesth Analg 74:231-235, 1992.
8. Kharasch ED, Thummel KE: Identification of cytochrome P-450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79:795-807, 1993.
9. Kharasch ED, Hankins DC, Cox K: Clinical isoflurane metabolism by cytochrome P-450 2E1. Anesthesiology 90:766-771, 1999.
10. Chen TL, Ueng TH, Chen SH, Lee PH, Fan SZ, Liu CC: Human cytochrome P-450 monooxygenase system is suppressed by propofol. Br J Anaesth 74:558-562, 1995.
11. Baker MT, Chadam MV, Ronnenberg WC Jr.: Inhibitory effects of propofol on cytochrome P-450 activities in rat hepatic microsomes. Anesth Analg 76:817-821, 1993.
12. Phares CK: Streptozotocin-induced diabetes in Syrian hamster: New model of diabetes mellitus. Experientia 36:681-682, 1980.
13. Alvares AP, Mannering GJ: Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Mol Pharmacol 6:206-211, 1970.
14. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951.
15. Fry BW, Taves DR: Serum fluoride analysis with the fluoride electrode. J Lab Clin Med 75:1020-1025, 1970.
16. Imai Y, Ito A, Sato R: Evidence for biochemically different types of vesicles in the hepatic fraction. J Biochem (Tokyo) 60:417-428, 1966.
17. Nash T: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416-421, 1953.
18. Lubet RA, Mayer JW, Cameron RW, Nims MD, Burke TW, Guengerich FP: Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics. Arch Biochem Biophys 238:43-48, 1985.
19. Nebert DW, Gelboin HV: Substrate-inducible microsomal aryl hydroxylase in the mammalian cell culture. I: Assembly and properties of induced enzyme. J Biol Chem 243:6242-6249, 1968.
20. Pantuck EJ, Pantuck CB, Conney AH: Effect of streptozotocin-induced diabetes in the rats on the metabolism of fluorinated volatile anesthetics. Anesthesiology 66:24-28, 1987.
21. Lange H, Stephan H, Rieke H, Kellemann M, Sonntag H, Bircher J: Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery. Br J Anaesth 64:563-570, 1990.
22. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Knott S, Ruane RJ: Species differences in the blood profiles, metabolism and excretion of 14C-propofol after intravenous dosing to rat, dog and rabbit. Xenobiotica 21:1243-1256, 1991.
23. Chen TL, Wang MJ, Huang CH, Liu CC, Ueng TH: Difference between in vivo and in vitro effects of propofol on defluorination and metabolic activities of hamster hepatic cytochrome P-450-dependent monooxygenases. Br J Anaesth 75: 462-466, 1995.
24. Mazze RI, Cousins MJ, Kosek JC: Dose-related methoxyflurane nephrotoxicity in rats: A biochemical and pathologic correlation. Anesthesiology 36: 571-587, 1972.
25. Mazze RI: Fluorinated anaesthetic nephrotoxiccity: An update. Can Anaesth Soc J 31 (Suppl):S16-22, 1984.
26. Kharasch ED, Hankins DC, Thummel KE: Human kidney methoxyflurane and sevoflurane metabolism: Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 82:689-699, 1995.
27. Kharasch ED, Thummel KE: Human alfentanil metabolism by cytochrome P-450 3A3/4: An explanation for the interin-dividual variability in alfentanil clearance. Anesth Analg 76: 1033-1039, 1993.
28. Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA: Oxidation of midazolam and triazolam by human liver cytochrome P-450 IIIA4. Mol Pharmacol 36:89-96, 1989.
29. Claeys MA, Gepts E, Camu F: Haemodynamic changes during anaesthesia and maintained with propofol. Br J Anaesth 60:3-9, 1988.
30. Runciman WB, Mather LE, Selby DG: Cardiovascular effects of propofol and of thiopentone anaesthesia in the sheep. Br J Anaesth 65: 353-359, 1990.